Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

New Lilly Blood Thinner Finally Reaches US Pharmacies

By Pharmaceutical Processing | August 5, 2009

INDIANAPOLIS (AP) — Eli Lilly and Co. said Wednesday the blood thinner Effient has finally reached U.S. pharmacy shelves. The Indianapolis company said Effient is now available across the United States. The Food and Drug Administration approved it on July 10 after delaying its decision several times during an 18-month review. European regulators approved the drug in February. The FDA has said the drug will carry a boxed warning to alert physicians to the risks of “significant, sometimes fatal, bleeding” in some patients. Effient prevents platelets from sticking together and forming potentially dangerous clots. It is approved for patients undergoing angioplasty, a procedure in which an inflatable balloon is used to clear arteries clogged with plaque, which are often propped open with a stent. Effient will compete with Plavix, the world’s second-best selling medication, made by Sanofi-Aventis and Bristol-Myers Squibb. Some analysts have said Effient could eventually exceed $1 billion in annual sales. That would provide a crucial revenue source for Lilly, which faces patent expirations for several top-selling drugs starting in 2011. But Lilly will share Effient revenue with Japanese drugmaker and Effient co-developer Daiichi Sankyo Co.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE